Mississippi Practice Structure Guide: Board Policy 3.02, the Professional Corporation Act and the August 2026 Peptide Statement

Entity and Ownership

The Mississippi Professional Corporation Act requires articles stating the corporation is a professional corporation with a single professional purpose. The name must contain professional corporation, professional association, P.C. or P.A. and meet licensing-authority rules. Shares may go only to individuals authorized to render the service, qualifying professional corporations and partnerships and others the licensing authority authorizes. Violating shares are void, proxies, voting trusts and transfers are limited to qualified persons, shares are compulsorily bought out on death or disqualification and the annual report certifies shareholders. The Board's Policy 3.02 says shareholders of a professional corporation rendering medical services shall only be licensed physicians, which is narrower than the statute, so we use physician-only shareholders. We found no board registration. The Attorney General may seek judicial dissolution after notice.

The Corporate Practice Position

There is no corporate practice statute. The Board's Policy 3.02, reproduced as last revised in December 2025, says the Board will not concern itself with the form or type of business arrangements entered into by a licensee provided the physician is licensed, patient treatment is left to the physician's sole and absolute discretion free of any influence, billing and fees are left solely to the physician, no consideration is received as an inducement for referrals, the arrangement complies with the Anti-Kickback Statute, patient free choice is preserved, licensed physicians have sole responsibility for approving public communications and advertisements, and shareholders of a medical professional corporation are physicians only. The Board calls these policies and not rules, and says a conflicting statute or rule controls.

An ABA article says the doctrine rests on case law, and the optometry decisions we verified are statute-based holdings that a corporation cannot practice optometry through a licensed employee. We found no decision or Attorney General opinion applying a doctrine to physicians. The Board's September 2023 IV guidance says neither a business nor a business owner can lawfully exercise control over the manner in which a physician provides services or interfere with independent medical judgment, and that assisting an unlicensed person to practice, including serving as medical director without ensuring qualified personnel do each task, is unprofessional conduct.

The Management Agreement and Fees

We found no fee-splitting statute or rule. The operative limits are Policy 3.02's rules on billing, referral inducements and anti-kickback compliance, a prescribing rule that bars being influenced by a financial interest in a pharmaceutical firm, pharmacy or supplier, which matters if an MSO affiliate owns one, and a policy on exclusive distributorships and personal branding. We found no authority on percentage fees. The Board's administrative code says records remain the property of the licensee in whose facility they are maintained and sets 10-year retention beginning January 1, 2026, and its advertising rules require a named responsible physician on all ads and bar superlatives and non-approved drug uses. A dispensing physician must register and personally dispense. Non-competes follow common-law reasonableness, and bills to ban healthcare non-competes reportedly died in committee. We found no transaction notice law.

Med Spa, IV and Peptide Rules

Mississippi has no med spa statute or license. Board rules treat lasers and pulsed light as the practice of medicine and limit use to physicians and those directly supervised by physicians with a physician on the premises, and a joint policy lets a nurse practitioner administer Botox with the collaborating physician's documented exam. The Board's IV guidance requires a valid practitioner-patient relationship, a history, a diagnosis and an individual prescription, and the Nursing Board's 2025 statement requires an individualized order, bars standing orders and bars nurses from compounding. Telemedicine requires a Mississippi license, and a simple questionnaire without an appropriate exam violates the rule.

The August 2026 joint statement of the medical, nursing and pharmacy boards says under no circumstances may a provider compound, administer or dispense a non-FDA-approved or research-grade peptide, forbids delegating purchase or administration, says consent forms labeling a product research-grade do not reduce liability and requires buying only from pharmacy-board-permitted entities.

How We Structure It

As a rule we set up a professional corporation owned by the licensed physician, with no exceptions for what looks like a more flexible state. Patients pay the physician-owned practice. The practice pays the management company a fixed monthly fee under a written management services agreement. The management company pays MedGrid a fixed monthly retainer for consulting. The MSO never practices medicine, and the physician makes every clinical decision. In Mississippi the physician approves every public communication, the shareholders are physicians only and peptides come only from permitted sources.

Disclaimer

This article is general educational information, not legal advice. Entity and corporate practice rules change, and parts of this summary rest on secondary sources, so have health care counsel in the state confirm the structure before you form or sign anything.